- Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
04/10/2021 / 19:31 - GlobeNewswire
-
- Advaxis Presents Translational Biomarker Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the American Associated for Cancer Research (AACR) 2021 Annual Meeting
04/10/2021 / 14:31 - GlobeNewswire
-
- OncXerna Therapeutics Provides New Results from its Xerna™ RNA-based Biomarker Platform at the AACR Annual Meeting
04/10/2021 / 14:30 - GlobeNewswire
-
- Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer
04/08/2021 / 14:00 - GlobeNewswire
-
- PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system
04/07/2021 / 22:01 - GlobeNewswire
-
- F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration
04/01/2021 / 14:00 - GlobeNewswire
-
- Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
03/18/2021 / 12:00 - GlobeNewswire
-
- Immutep Enters Second Collaboration With MSD For A New Randomised Phase IIB Trial In Head And Neck Cancer
03/16/2021 / 13:00 - GlobeNewswire
-
- Gilead, Merck jointly developing new HIV drug
03/15/2021 / 11:26 - TeleTrader
-
- J&J to deliver additional 100M doses in H2 - WH
03/10/2021 / 20:12 - TeleTrader
-
- Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer
03/09/2021 / 13:10 - GlobeNewswire
-
- COVID-19 drug efficient in reducing infection after 5 days - trial
03/06/2021 / 10:05 - TeleTrader
-
- WH: Biden admin sped up J&J, Merck deal
03/02/2021 / 19:15 - TeleTrader
-
- Merck to help J&J manufacture COVID vaccine - report
03/02/2021 / 14:07 - TeleTrader
-
- Merck to buy Pandion in $1.8 billion cash deal
02/25/2021 / 12:57 - TeleTrader
Real-time